Neridronate Inhibitor

Neridronate is an aminobisphosphonate, for the treatment,of osteogenesis imperfecta (OI) and Paget's disease of bone (PDB).

Gatti D, et al. Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag. 2013;9:139-47.
Gatti D, et al. Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag. 2013;9:139-47.
Guiducci L, et al. Monthly Intramuscular Neridronate for the treatment,of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study. Int J Endocrinol. 2019 Feb 6;2019:9802827.
Guiducci L, et al. Monthly Intramuscular Neridronate for the treatment,of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study. Int J Endocrinol. 2019 Feb 6;2019:9802827.

Small volumes of Neridronate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5754350 is an inhibitor targeting Neridronate.